Leading the Way: The Future of Wound Care
Lavior is honored to be a part of the 2023 Annual APWCA Wound Week, scheduled from September 20th to 24th, hosted at the Marriott Downtown Philadelphia. This event promises to be a remarkable convergence of pioneering minds and medical experts from across the nation. It will serve as a platform to explore innovative advancements in wound care, ranging from oxygen therapy to collagen peptides, and even the integration of artificial intelligence in treatment. With a shared commitment to shaping the trajectory of wound care, leading physicians and clinicians will convene to chart a course towards a promising future in wound management.
Lavior: A Natural Innovation
In the face of a growing health crisis, where diabetes has surged to affect over 37 million individuals in the United States, it’s become increasingly evident that innovative solutions in wound care desperately needed. Over the past three decades, diabetes has more than tripled, with contributing factors like obesity, poor nutrition, and a sedentary lifestyle exacerbating the problem across all age groups. The systemic challenges posed by diabetes have given rise to alarming statistics: each year, a staggering 5.5 million American diabetics struggle with wounds that defy conventional treatments, leading to over 150,000 amputations and 75,000 deaths per year.
Unlike conventional approaches that merely manage wounds, Lavior heals them. In a landscape where diabetes-related wounds often spiral into chronic, life-altering conditions, Lavior’s commitment to providing an effective, affordable, and accessible solution is nothing short of revolutionary. By addressing the root causes of these persistent wounds, Lavior offers hope, promising not just wound management but actual healing, reshaping the trajectory of diabetic wound care in a profoundly impactful way.
Dr. Oscar Barreto and Peter Hurwitz will present a case study on the successful treatment of a medial malleolus ulcer (venous ulcer) using the Lavior botanical-based, wound care supercharged hydrogel on a patient with significant comorbidities. With its anti-inflammatory, antifungal, antibacterial properties, nontoxicity, as well as targeting the overstimulation of cytokine secretion, this unique wound care supercharged hydrogel shows promise in addressing the underlying causes while promoting healing of chronic wounds.
About The American Professional Wound Care Association (APWCA)
The American Professional Wound Care Association® (APWCA) is a non-profit medical association welcoming medical providers from all disciplines involved in prevention and treatment of difficult wounds. Through a synergy of disciplines, APWCA has been a worldwide leader in clinician advocacy and education for the prevention and treatment of acute and chronic wounds since 2001. This association provides an informational and educational forum for healthcare providers, while promoting excellence in wound healing and patient advocacy.
